Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Artificial strain of human prions created in vitro.

Kim C, Xiao X, Chen S, Haldiman T, Smirnovas V, Kofskey D, Warren M, Surewicz K, Maurer NR, Kong Q, Surewicz W, Safar JG.

Nat Commun. 2018 Jun 4;9(1):2166. doi: 10.1038/s41467-018-04584-z.

2.

Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.

Drummond E, Nayak S, Faustin A, Pires G, Hickman RA, Askenazi M, Cohen M, Haldiman T, Kim C, Han X, Shao Y, Safar JG, Ueberheide B, Wisniewski T.

Acta Neuropathol. 2017 Jun;133(6):933-954. doi: 10.1007/s00401-017-1691-0. Epub 2017 Mar 4.

3.

Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.

Mays CE, van der Merwe J, Kim C, Haldiman T, McKenzie D, Safar JG, Westaway D.

J Virol. 2015 Dec;89(24):12418-26. doi: 10.1128/JVI.02142-15. Epub 2015 Sep 30.

4.

Structural determinants of phenotypic diversity and replication rate of human prions.

Safar JG, Xiao X, Kabir ME, Chen S, Kim C, Haldiman T, Cohen Y, Chen W, Cohen ML, Surewicz WK.

PLoS Pathog. 2015 Apr 14;11(4):e1004832. doi: 10.1371/journal.ppat.1004832. eCollection 2015 Apr.

5.

Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Cohen ML, Kim C, Haldiman T, ElHag M, Mehndiratta P, Pichet T, Lissemore F, Shea M, Cohen Y, Chen W, Blevins J, Appleby BS, Surewicz K, Surewicz WK, Sajatovic M, Tatsuoka C, Zhang S, Mayo P, Butkiewicz M, Haines JL, Lerner AJ, Safar JG.

Brain. 2015 Apr;138(Pt 4):1009-22. doi: 10.1093/brain/awv006. Epub 2015 Feb 15.

6.

Prion disease tempo determined by host-dependent substrate reduction.

Mays CE, Kim C, Haldiman T, van der Merwe J, Lau A, Yang J, Grams J, Di Bari MA, Nonno R, Telling GC, Kong Q, Langeveld J, McKenzie D, Westaway D, Safar JG.

J Clin Invest. 2014 Feb;124(2):847-58. doi: 10.1172/JCI72241. Epub 2014 Jan 16.

7.

Co-existence of distinct prion types enables conformational evolution of human PrPSc by competitive selection.

Haldiman T, Kim C, Cohen Y, Chen W, Blevins J, Qing L, Cohen ML, Langeveld J, Telling GC, Kong Q, Safar JG.

J Biol Chem. 2013 Oct 11;288(41):29846-61. doi: 10.1074/jbc.M113.500108. Epub 2013 Aug 23.

8.

Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C).

Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Kong Q, Telling GC, Surewicz WK, Safar JG.

PLoS Pathog. 2012;8(8):e1002835. doi: 10.1371/journal.ppat.1002835. Epub 2012 Aug 2.

9.

Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.

Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Safar JG.

PLoS Pathog. 2011 Sep;7(9):e1002242. doi: 10.1371/journal.ppat.1002242. Epub 2011 Sep 8.

Supplemental Content

Loading ...
Support Center